Probability of pancreatic cancer following diabetes: A population-based study

Gastroenterology

Volumn 129, Issue 2, 2005, Pages 504-511

  Chari, Suresh T ^a,b   Leibson, Cynthia L ^b   Rabe, Kari G ^b   Ransom, Jeanine ^b   De Andrade, Mariza ^b   Petersen, Gloria M ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CANCER SURGERY; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; REGISTER; SMOKING HABIT; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

EID: 23244467796     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gastro.2005.05.007     Document Type: Article

References (46)

1. T.A. Brentnall, M.P. Bronner, D.R. Byrd, R.C. Haggitt, M.B. Kimmey Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer Ann Intern Med 131 1999 247 255
2. M. Canto, L. Wroblewski, M. Goggins, G. Petersen, K. Brune, C. Yea, F. Giardello, R. Hruban Screening for pancreatic neoplasia in high-risk individuals The Johns Hopkins Experience Gastroenterology 122 Suppl 1 2002 A-17
3. M. Goggins, M. Canto, R. Hruban Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 74 2000 243 248
4. J. Everhart, D. Wright Diabetes mellitus as a risk factor for pancreatic cancer a meta-analysis JAMA 273 1995 1605 1609
5. M. Ragozzino, L.J.D. Melton, C.P. Chu, P.J. Palumbo Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus J Chronic Dis 35 1982 13 19
6. L. Wideroff, G. Gridley, L. Mellemkjaer, W.H. Chow, M. Linet, S. Keehn, K. Borch-Johnsen, J.H. Olsen Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 89 1997 1360 1365
7. E.E. Calle, T.K. Murphy, C. Rodriguez, M.J. Thun, C.W. Heath Jr Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults Cancer Causes Control 9 1998 403 410
8. H.O. Adami, J. McLaughlin, A. Ekbom, C. Berne, D. Silverman, D. Hacker, I. Persson Cancer risk in patients with diabetes mellitus Cancer Causes Control 2 1991 307 314
9. W.H. Chow, G. Gridley, O. Nyren, M.S. Linet, A. Ekbom, J.F. Fraumeni Jr, H.O. Adami Risk of pancreatic cancer following diabetes mellitus a nationwide cohort study in Sweden J Natl Cancer Inst 87 1995 930 931
10. E. Cersosimo, P.W. Pisters, G. Pesola, K. McDermott, D. Bajorunas Insulin secretion and action in patients with pancreatic cancer Cancer 67 1991 486 493
11. J. Permert, I. Ihse, L. Jorfeldt, H. von Schenck, H.J. Arnqvist, J. Larsson Pancreatic cancer is associated with impaired glucose metabolism Eur J Surg 159 1993 101 107
12. J. Permert, J. Larsson, I. Ihse, P.M. Pour Diagnosis of pancreatic cancer. Alteration of glucose metabolism Int J Pancreatol 9 1991 113 117
13. S.T. Chari, G.G. Klee, L.J. Miller, M. Raimondo, E.P. DiMagno Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer Gastroenterology 121 2001 640 645
14. D.T. Silverman, C.A. Swanson, G. Gridley, S. Wacholder, R.S. Greenberg, L.M. Brown, R.B. Hayes, G.M. Swanson, J.B. Schoenberg, L.M. Pottern, A.G. Schwartz, J.F. Fraumeni Jr, R.N. Hoover Dietary and nutritional factors and pancreatic cancer a case control study based on direct interviews J Natl Cancer Inst 90 1998 1710 1719
15. M. Jain, G.R. Howe, P. St Louis, A.B. Miller Coffee and alcohol as determinants of risk of pancreas cancer a case control study from Toronto Int J Cancer 47 1991 384 389
16. L. Gullo, R. Pezzilli, A.M. Morselli-Labate Italian Pancreatic Cancer Study Group Diabetes and the risk of pancreatic cancer N Engl J Med 331 1994 81 84
17. A.R. Moossa, B. Levin Collaborative studies in the diagnosis of pancreatic cancer Semin Oncol 6 1979 298 308
18. A.R. Moossa, B. Levin The diagnosis of "early" pancreatic cancer the University of Chicago experience Cancer 47 1968 1688 1697
19. L. Bonelli, H. Aste, P. Bovo, G. Cavallini, M. Felder, R. Gusmaroli, E. Morandini, P. Ravelli, R. Briglia, L. Lombardo, A. De Micheli, V. Pugliese Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus a case-control study in northern Italy Pancreas 27 2003 143 149
20. J. Cuzick, A.G. Babiker Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease Int J Cancer 43 1989 415 421
21. J. Permert, I. Ihse, L. Jorfeldt, H. von Schenck, H.J. Arnquist, J. Larsson Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer Br J Surg 80 1993 1047 1050
22. A. Noy, J.P. Bilezikian Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy J Clin Endocrinol Metab 79 1994 1223 1231
23. W. Levine, A.R. Dyer, R.B. Shekelle, J.A. Schoenberger, J. Stamler Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry Am J Epidemiol 131 1990 254 262
24. S.M. Gapstur, P.H. Gann, W. Lowe, K. Liu, L. Colangelo, A. Dyer Abnormal glucose metabolism and pancreatic cancer mortality JAMA 283 2000 2552 2558
25. G.D. Smith, M. Egger, M.J. Shipley, M.G. Marmot Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men Am J Epidemiol 136 1992 1110 1114
26. L.J. Melton III History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
27. J.P. Burke, P. O'Brien, J. Ransom, P.J. Palumbo, E. Lydick, B.P. Yawn, L. Joseph Melton III, C.L. Leibson Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota Am J Epidemiol 155 2002 859 865
28. C.L. Leibson, D.F. Williamson, L.J. Melton III, P.J. Palumbo, S.A. Smith, J.E. Ransom, P.L. Schilling, K.M. Narayan Temporal trends in BMI among adults with diabetes Diabetes Care 24 2001 1584 1589
29. R.J. Thomas, P.J. Palumbo, L.J. Melton III, V.L. Roger, J. Ransom, P.C. O'Brien, C.L. Leibson Trends in the mortality burden associated with diabetes mellitus a population-based study in Rochester, Minn, 1970-1994 Arch Intern Med 163 2003 445 451
30. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes Care 28 1979 1039 1057
31. K. West Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies Diabetes Care 2 1979 65 76
32. L.J. Melton III The threat to medical-records research N Engl J Med 337 1997 1466 1470
33. National Cancer Institute. Surveillance and End Results (SEER) Program (www.seer.cancer.gov ) SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov 2002 Sub (1973-2000) <18 Age Groups>, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
34. A. Riela, A.R. Zinsmeister, L.J. Melton III, L.H. Weiland, E.P. DiMagno Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988 Mayo Clin Proc 67 1992 839 845
35. Bergstalh EJ, Offord KP, Kosanke JL, Augustine GA. PERSONYEARS: a SAS procedure for person year analyses: Rochester, MN: Section of Medical Research Statistics, Mayo Clinic; April 1986. Technical Report Series, No.31.
36. N.E. Breslow, N.E. Day Statistical methods in cancer research. IARC Workshop. IARC Scientific Publications. Volume No. 82 1987 IARC Lyon, France
37. J.P.W.K. Burke, S.P. Gaskill, H.P. Hazuda, S.M. Haffner, M.P. Stern Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 results from the San Antonio Heart Study Arch Intern Med 159 1999 1450 1456
38. J. Damiano, L. Bordier, J.P. Le Berre, J. Margery, O. Dupuy, H. Mayaudon, B. Bauduceau Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms? Diabetes Metab 30 2004 203 207
39. Y. Ogawa, M. Tanaka, K. Inoue, K. Yamaguchi, K. Chijiiwa, K. Mizumoto, N. Tsutsu, Y. Nakamura A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus Cancer 94 2002 2344 2349
40. S. Gangi, J.G. Fletcher, M.A. Nathan, J.A. Christensen, W.S. Harmsen, B.S. Crownhart, S.T. Chari Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer retrospective review of CT scans obtained before diagnosis AJR Am J Roentgenol 182 2004 897 903
41. R. Tsuchiya, T. Noda, N. Harada, T. Miyamoto, T. Tomioka Collective review of small carcinomas of the pancreas Ann Surg 203 1986 77 81
42. B. Ahren, A. Andren-Sandberg Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster Res Exp Med 193 1993 21 26
43. M.I. Harris, R. Klein, T.A. Welborn, M.W. Knuiman Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis Diabetes Care 15 1992 815 819
44. M.I.F.K. Harris, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, R.R. Little, H.M. Wiedmeyer, D.D. Byrd-Holt Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care 21 1998 518 524
45. D. Basso, A. Valerio, R. Seraglia, S. Mazza, M.G. Piva, E. Greco, P. Fogar, N. Gallo, S. Pedrazzoli, A. Tiengo, M. Plebani Putative pancreatic cancer-associated diabetogenic factor 2030 MW peptide Pancreas 24 2002 8 14
46. A.S.S. Berrington de Gonzalez, E. Spencer A meta-analysis of obesity and the risk of pancreatic cancer Br J Cancer 89 2003 519 523